The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

INTRODUCTION: SUPREMO is a phase 3 randomised trial evaluating radiotherapy post-mastectomy for intermediate-risk breast cancer. 1688 patients were enrolled from 16 countries between 2006 and 2013. We report the results of central pathology review carried out for quality assurance. PATIENTS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, J. S., Hanby, A. M., Russell, N., van Tienhoven, G., Riddle, K., Anderson, N., Cameron, D. A., Bartlett, J. M. S., Piper, T., Cunningham, C., Canney, P., Kunkler, I. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387007/
https://www.ncbi.nlm.nih.gov/pubmed/28190252
http://dx.doi.org/10.1007/s10549-017-4145-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387007/
https://www.ncbi.nlm.nih.gov/pubmed/28190252
http://dx.doi.org/10.1007/s10549-017-4145-4

Ejemplares similares